Reaction
Emphysematous Cystitis reporting signals
As of the last recalculation, Emphysematous Cystitis appears in 211 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is GEFITINIB (PRR 55.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Gefitinib | 5 | 55.9 | 56.0 |
| Dapagliflozin | 14 | 47.0 | 47.0 |